About David Adamson, MD, Founder and CEO David Adamson is a consulting reproductive endocrinologist and surgeon, Medical Director of Equal3 Fertility, Clinical Professor ACF at Stanford University, and Associate Clinical Professor at UCSF. He is Past President of the ASRM, SART, AAGL, the Committee on Reproductive Medicine for FIGO and several
Author: Editor
Industry News: Volume 3, Issue 20
Americans don’t need Biden to dictate their health care coverage By Virginia Foxx washingtontimes.com - Over 150 million Americans get their health care coverage from their employer through employer-sponsored insurance. These plans provide employees with access to high-quality, low-cost health care. The plans also have the flexibility to include added benefits for
Volume 3, Issue 19: John Roos, Co-Founder & EVP, Aphora Health Discusses Introducing International Healthcare to U.S. Employer Markets
Dear Colleagues, Medical travel has gained considerable attention worldwide for its potential for cost saving and high-quality treatment options. Despite this growing popularity, you may be surprised to learn that the U.S. employer market has yet to explore the benefits of offering medical travel as an employee healthcare option. This issue brings
Spotlight Interview: John Roos, Co-Founder & EVP, Aphora Health
About John Roos, Co-Founder & EVP John Roos joined Aphora Health in September 2022. After retiring from Blue Cross Blue Shield North Carolina at the end of 2020, he formed Thirty-Four Consulting, LLC, to offer his industry expertise to health plans, employers, providers, and health technology companies. At Blue Cross, Roos
Industry News: Volume 3, Issue 19
Medical crowdfunding isn’t a solution for skyrocketing health care costs By Annalisa Merelli statnews.com - In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social network into a financial safety net to cover the cost of expensive
Volume 3, Issue 18: Sanjiv Tandon, Global Leader, Life Sciences and Healthcare & Robert Baldry, Life Science Regulatory Affairs Transformation Leader at Genpact Discuss Human-Centered Approach to AI Adoption in Life Sciences
Dear Colleagues, I am excited to share my recent article published in the May issue of The Self Insurer discussing how employers are navigating new frontiers in cell and gene therapy. Please find this article in the Self-Insurer section of our website, where you can access my monthly articles written for the publication. In
Feature Article: Sanjiv Tandon, Global Leader, Life Sciences and Healthcare & Robert Baldry, Life Sciences Regulatory Affairs Transformation Leader, Genpact
About Sanjiv Tandon, Global Leader Sanjiv has 23+ years of experience in Sales & Business Development, Operations & Service Delivery and Client Servicing & Relationship Management across multiple industry verticals including Life Sciences, Consumer Products, and Financial Services. About Robert Baldry, Life Science Regulatory Affairs Transformation Leader Robert Baldry, Life Science Regulatory Affairs
Industry News: Volume 3, Issue 18
UnitedHealth CEO estimates one-third of Americans could be impacted by Change Healthcare cyberattack By Ashley Capoot cnbc.com - UnitedHealth Group CEO Andrew Witty on Wednesday told lawmakers that data from an estimated one-third of Americans could have been compromised in the cyberattack on its subsidiary Change Healthcare, and that the company paid a $22 million
May 2024: Employers Navigate New Frontiers in Cell and Gene Therapy
Volume 3, Issue 17: Brandon Welch, MS, PhD, Founder & CEO, Doxy.me Discusses Simplified Telemedicine Post-Pandemic
Dear Colleagues, In this issue, we speak with Brandon Welch, MS, PhD, Founder & CEO, Doxy.me about the importance of simplified and user-friendly telemedicine. We are also sharing the most pressing news in healthcare today including pandemic preparation for the future in the United States, person-centered primary care and more about the